Hiprex (Methenamine Hippurate): Uses and Mechanism of Action
Hiprex (methenamine hippurate) is used for prophylactic or suppressive treatment of frequently recurring urinary tract infections (UTIs) when long-term therapy is considered necessary, serving as an antimicrobial-sparing alternative to antibiotics in patients with intact bladder function. 1
Mechanism of Action
Methenamine hippurate works through a unique mechanism that differs from conventional antibiotics:
Formaldehyde Production: When methenamine reaches the bladder, it hydrolyzes in acidic urine to release formaldehyde and ammonia 2
Bacteriostatic Effect: The released formaldehyde acts as a denaturant of bacterial proteins and nucleic acids, creating a broad-spectrum bacteriostatic effect against urinary pathogens 2
pH Dependency: The antimicrobial activity is dependent on:
- Acidic urinary pH (ideally below 6.0)
- Concentration of methenamine in urine
- Time the drug remains in the bladder 2
Clinical Applications
Methenamine hippurate is particularly useful in:
- Prevention of recurrent UTIs in patients aged 12 years and older 1
- Alternative to prophylactic antibiotics in patients with intact bladder anatomy 2
- Patients without incontinence and with fully functional bladders 2
Dosing
- Standard dosage: 1 g twice daily 2
- Alternative formulation (methenamine mandelate): 1 g every 6 hours 2
Advantages Over Antibiotics
- No development of bacterial resistance: Unlike conventional antibiotics, acquired resistance to methenamine hippurate does not appear to develop 2
- Non-inferiority to antibiotics: Recent evidence shows methenamine hippurate is non-inferior to daily low-dose antibiotics for preventing recurrent UTIs 2
- Similar adverse effects profile to antibiotics used for UTI prophylaxis 2
Important Considerations
Urinary pH: Maintaining urinary pH below 6.0 is necessary for optimal efficacy 2
- Methods to acidify urine may include:
- Ascorbic acid (vitamin C), though doses up to 4g/day may have limited effect
- Ammonium chloride may be more effective but is less commonly used 2
Patient Selection: Most effective in:
- Patients with intact bladder anatomy
- Those without long-term catheterization 2
Not for Active Infection: Methenamine hippurate is primarily for prevention rather than treatment of established UTIs 1
Limitations
- Not recommended for patients with long-term indwelling urethral or suprapubic catheterization 2
- Limited efficacy in treating established UTI infections 3
- Requires acidic urine to be effective, which may be difficult to maintain consistently 2
Methenamine hippurate represents an important antimicrobial-sparing option for UTI prevention, particularly valuable in the context of increasing antibiotic resistance concerns.